5/10
11:51 am
ardx
Ardelyx: Strong Execution, Fairly Valued [Seeking Alpha]
Low
Report
Ardelyx: Strong Execution, Fairly Valued [Seeking Alpha]
5/7
08:14 am
ardx
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference [Yahoo! Finance]
Low
Report
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference [Yahoo! Finance]
5/7
08:01 am
ardx
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
Low
Report
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
5/4
11:12 am
ardx
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/4
09:21 am
ardx
Ardelyx First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
Ardelyx First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
5/3
08:00 pm
ardx
Ardelyx, Inc. (NASDAQ: ARDX) had its price target raised by analysts at Citigroup Inc. from $13.00 to $14.00. They now have a "buy" rating on the stock.
Medium
Report
Ardelyx, Inc. (NASDAQ: ARDX) had its price target raised by analysts at Citigroup Inc. from $13.00 to $14.00. They now have a "buy" rating on the stock.
5/3
12:41 pm
ardx
Ardelyx Stock: A Crowded Market Curbs The Enthusiasm (Rating Downgrade) [Seeking Alpha]
Low
Report
Ardelyx Stock: A Crowded Market Curbs The Enthusiasm (Rating Downgrade) [Seeking Alpha]
5/3
09:57 am
ardx
Ardelyx, Inc. (NASDAQ: ARDX) had its price target raised by analysts at Wedbush from $14.00 to $15.00. They now have an "outperform" rating on the stock.
Medium
Report
Ardelyx, Inc. (NASDAQ: ARDX) had its price target raised by analysts at Wedbush from $14.00 to $15.00. They now have an "outperform" rating on the stock.
5/2
04:56 pm
ardx
Ardelyx: Q1 Earnings Snapshot [Yahoo! Finance]
High
Report
Ardelyx: Q1 Earnings Snapshot [Yahoo! Finance]
5/2
04:13 pm
ardx
Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
5/2
04:02 pm
ardx
Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
High
Report
Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
5/1
08:00 am
ardx
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings
Medium
Report
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings
4/25
11:44 am
ardx
Ardelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release [Yahoo! Finance]
Low
Report
Ardelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release [Yahoo! Finance]
4/23
08:35 pm
ardx
Utilization of Food Grade Phosphate to Rise at 8% per year. The Global Food Grade Phosphate Market Value to Surpass US$ 6,685.7 Million by 2034 end | Future Market Insights, Inc. [Yahoo! Finance]
Low
Report
Utilization of Food Grade Phosphate to Rise at 8% per year. The Global Food Grade Phosphate Market Value to Surpass US$ 6,685.7 Million by 2034 end | Future Market Insights, Inc. [Yahoo! Finance]
4/23
03:05 pm
ardx
Ardelyx's (NASDAQ:ARDX) investors will be pleased with their favorable 91% return over the last five years [Yahoo! Finance]
Low
Report
Ardelyx's (NASDAQ:ARDX) investors will be pleased with their favorable 91% return over the last five years [Yahoo! Finance]
4/18
09:17 am
ardx
World IBS Day - April 19th: Raising Awareness for Everyone with IBS [Yahoo! Finance]
Low
Report
World IBS Day - April 19th: Raising Awareness for Everyone with IBS [Yahoo! Finance]
4/18
08:00 am
ardx
Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
Low
Report
Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
4/11
06:58 pm
ardx
First National Phosphorus Awareness Day Engages 50,000 People [Yahoo! Finance]
Medium
Report
First National Phosphorus Awareness Day Engages 50,000 People [Yahoo! Finance]
4/9
06:02 am
ardx
Ardelyx, Inc. (NASDAQ: ARDX) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
Low
Report
Ardelyx, Inc. (NASDAQ: ARDX) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
4/5
07:25 am
ardx
Ardelyx, Inc. (NASDAQ: ARDX) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $14.00 price target on the stock.
Low
Report
Ardelyx, Inc. (NASDAQ: ARDX) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $14.00 price target on the stock.
3/28
04:05 pm
ardx
Ardelyx, Inc. Reports Employment Inducement Grants
Low
Report
Ardelyx, Inc. Reports Employment Inducement Grants
3/25
08:06 am
ardx
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy [Yahoo! Finance]
Low
Report
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy [Yahoo! Finance]
3/25
08:00 am
ardx
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy
Low
Report
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy
3/21
02:18 pm
ardx
Bull Signal Says Buy This Biopharmaceutical Stock Now [Yahoo! Finance]
Low
Report
Bull Signal Says Buy This Biopharmaceutical Stock Now [Yahoo! Finance]
3/21
11:07 am
ardx
Institutional investors may overlook Ardelyx, Inc.'s (NASDAQ:ARDX) recent US$195m market cap drop as long-term gains remain positive [Yahoo! Finance]
Low
Report
Institutional investors may overlook Ardelyx, Inc.'s (NASDAQ:ARDX) recent US$195m market cap drop as long-term gains remain positive [Yahoo! Finance]